•
Jul 31, 2013

Summit Therapeutics Q2 2013 Earnings Report

Total Revenue
$384K
Previous year: $790K
-51.4%
EPS
-$0.0908
Previous year: -$0.125
-27.3%
Gross Profit
$166K
Previous year: $325K
-49.1%

Summit Therapeutics

Summit Therapeutics